NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC
NCT04405011
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
HBV/HCV Co-infection
Interventions
DRUG:
24-week Entecavir
DRUG:
12-week Entecavir
Sponsor
National Taiwan University Hospital